Microbiome Insights provides state-of-the art microbiome analysis and bioinformatics. Our end-to-end service starts from experimental design and sample collection to data analysis and bioinformatics interpretation.
Microbiome Insights is focused on providing our clients a deeper understanding of functions and interactions of microbial communities across a range of human, animal, agricultural and environmental research applications. Our team of experts and testing methods combine to provide fast, dependable, cost-effective results with highly comprehensive, publication quality bioinformatics
San Diego based, Therapeutics, Inc., The Dermatology CRO was founded in 1997. Approximately 90% of our activities are focused on developing dermatology products. TI is the only dermatology-focused CRO that provides all services required to move a product concept through non-clinical and clinical stages to FDA approval. During the last 5 years: TI managed >12,000 subjects in >80 clinical studies and filed 18 INDs and IDEs in a variety of drug, device and biologic programs.
CosmosID®, based in Rockville, MD, provides award-winning Next-Generation Sequencing & Bioinformatics solutions for unlocking the microbiome through rapid identification and characterization of microorganisms for pharmaceutical R&D, molecular diagnostics, public health, food safety, agriculture, and environmental applications. CosmosID’s CLIA-certified laboratories offer end-to-end solutions; from study design to sample collection, extraction, library preparation, sequencing, data analysis and publication support. Lastly, CosmosID’s user-friendly and independently validated cloud-based application returns strain-level metagenomic analyses with industry leading sensitivity & precision along with access to the world’s largest database for microbial genomics.
Loop Genomics is a DNA sequencing company with a vision to provide products that deliver the most complete and accurate human microbiome data. Loop technology meets the critical need for high-resolution phylogenetic data using long-read sequencing and single molecule abundance quantification, with an innovative approach that transforms existing short-read sequencing machines. Our long-read single molecule microbiome sequencing products enable drug R&D pipelines to discover previously inaccessible metagenomics information at unprecedented scale, while leveraging their existing sequencing systems and workflows.
Metabolon, Inc. is the world’s leading health technology company focused on the use of metabolomics in precision medicine and life sciences research. This powerful tool for assessing health is based on proprietary platforms and informatics that deliver biomarker discoveries, innovative diagnostic tests, and ground-breaking partnerships in genomics-based health initiatives.
Labskin’s pioneering approach for testing skincare products by cloning a patient’s skin microbiome and transplanting it on to Labskin Human Skin Equivalent, allows a wide range of testing that no longer requires invasive procedures on patients. Data from next generation sequencing of the Labskin and skin microbiome is coupled with AI processes to interpret and direct further development of skincare products in a controlled and efficient manner, reducing development time and costs.
Accelerate and transform your research across the entire project lifecycle and capitalize on the diverse opportunities of the microbome. Diversigen provides comprehensive microbiome, metagenomics, host genetic services, customized study design, and complex data analysis - all focused on solutions to improve human and animal health, environmental conditions, and agriculture production worldwide.
For L’Oréal, beauty is above all a scientific adventure. This principle is reflected in the key role played by its Research & Innovation division, which deploys its teams all around the world to dream up and create the products for tomorrow.
Boston Analytical is a cGMP compliant, FDA/DEA registered, ISO/IEC-17025:2005 accredited world class pharmaceutical testing laboratory. We provide identity, purity, and potency analyses necessary to characterize microbiome products and we have a proven track record on a variety of Microbiome programs including Spore Fraction and Defined Drug Product manufacturing processes. Boston Analytical employs LabWare Inc.’s™ LIMS and ELN software to help ensure on-time and accurate results.